拉丁美洲顏面注射劑市場：2011年

拉丁美洲顏面注射劑市場：2011年 是由出版商Millennium Research Group在2010年09月所出版的。 這份英文市場調查報告書價格從美金4897起跳。

簡介

本報告為，分析拉丁美洲顏面注射劑市場，並匯整肉毒桿菌、波尿酸皮膚注射、微粒聚合物填充等區隔別市場趨勢及預測、市場佔有率，以下列摘要形式闡述。

實施概要

方法論

第1章 拉丁美洲顏面注射劑市場

• 市場概要
• 市場分析
  • 最新趨勢
  • 產品概要
  • 處理
  • 市場預測
  • 市場驅力及阻力
• 競合分析
  • 競合環境
  • 市場佔有率
  • 競合企業
  • 新興企業

第2章 肉毒桿菌市場

• 市場概要
• 市場分析
  • 產品概要
  • 市場預測
  • 市場驅力及阻力
• 競合分析
  • 競合環境
  • 市場佔有率

第3章 皮膚注射市場

• 市場概要
• 市場分析
  • 產品概要
    • 波尿酸
    • 微粒聚合物填充
  • 市場預測
    • 波尿酸
    • 微粒聚合物填充
  • 市場驅力及阻力
• 競合分析
  • 競合環境
    • 波尿酸
    • 微粒聚合物填充
  • 市場佔有率

圖表

目錄

Abstract

The Latin American facial injectables market - comprising sales of botulinum toxin (BTX), hyaluronic acid (HA) dermal fillers, and particle and polymer fillers (PPFs) for cosmetic procedures in Argentina, Brazil, and Mexico - has exhibited strong growth for many years. Despite slowed growth in procedure volumes as a result of the 2008 financial crisis, prerecession growth rates have resumed with many people electing to try less invasive cosmetic procedures such as facial injectables. Revenue increases in this market will continue to be driven by strong economic development in a region with a significant emphasis on beauty and youth. Cosmetic procedures are highly socially accepted in Latin America, and many patients are drawn to the convenience, ease, and low-risk nature of facial injectables rather than cosmetic surgery. Furthermore, the region is attractive to medical tourists who want to combine their cosmetic surgical procedure with a vacation on some of the world' s most beautiful beaches. Because many cosmetic surgeons combine face-lifts and brow-lifts with facial injectables to boost the aesthetic effect, this trend will continue to support market growth in Latin America. The factor most significantly curtailing market growth is the high procedure cost relative to the earning power of most people in Latin America. Despite significant economic growth in the region, there remains a large gap in incomes with weaker consumer confidence among people with lower incomes. Nevertheless, aesthetic facial injectable products have developed a reputation for safety, effectiveness, and convenience among Latin Americans, and the temporary duration of cosmetic effects for many of these products will continue to support procedure volume growth through 2015.

METHODOLOGY

This report uses a number of methodologies to gather and present data and analysis. At the outset, a large survey of secondary sources is conducted. These sources act as the basis for the primary research stage, which builds and enhances the quantitative and qualitative attributes of the early research.

Secondary sources include

• Government sources:
  • Securities and Exchange Commission filings
  • Food and Drug Administration and patent filings
  • National Center for Health Statistics data
  • International Monetary Fund World Economic Outlook database
  • Organisation for Economic Cooperation and Development trade data
• Facial injectable companies:
  • Annual reports, product brochures, corporate profiles, etc.
• Internal databases and reports:
  • Previous reports on similar/related sources
• General Internet searches, medical literature, and newspaper/magazine searches:
  • Identifying various centers of specialization and articles that might provide leads for primary research

The secondary research stage builds the foundation for the primary research.

The primary research methodology has four steps:

Step 1: The first step involves an impartial scan of all the information gathered during the secondary research stage to determine its utility based on the specific requirements of this report. Each piece of information is either discarded or marked as high- or low-priority and then organized appropriately as determined by the structure and sectioning of the report.

Step 2: At this stage, early assumptions are formed as to the implications of the information for the various facial injectable market segments. These assumptions are then used to determine hypotheses using both inductive and deductive approaches. On the quantitative front, these hypotheses result in full historical and projected market data sets (market sizes - unit sales, average selling prices [ASPs], and revenues - as well as market shares).

Step 3: At this stage, the research is in position for its most important primary phase - expert interviews. Throughout the secondary research phase, industry and medical experts are identified. These experts are then contacted by telephone and asked to participate in interviews on recent trends and developments in the industry. Interviews are either conducted at the time of the initial call or scheduled at the convenience of the expert. Interview questions are tailored to the expertise of each particular interviewee, although in most cases, the most important questions are asked of all experts.

The questions are largely based on the assumptions and hypotheses developed in Step 2, which are then augmented, discarded, or adjusted based on the views and positions put forth. Attempts are made, whenever possible, to cross-check the views of various experts against each other and to reach positions of consensus on issues and market numbers.

Step 4: The final stage of primary research involves individual and group analysis by Millennium Research Group. All research results are assessed and cross-checked thoroughly to determine their validity, relevance, and weight. From this process, qualitative conclusions are reached and data points finalized.

In addition to the research methodology outlined above, the following “bottom-up” methodology is used to develop forecast assumptions for the report.

A comprehensive breakdown of various facial injectable procedures and unit sales is prepared using data from several sources, including professional associations, government statistics, and private research/media sources. Industry experts and practitioners are consulted to ensure accuracy and verify observed trends. As a cross-check, total industry revenues available through annual reports and other sources are compared against modeled industry revenues. Using the best estimates of industry experts, practitioners, private research/media sources, and inhouse experts, year-by-year growth rates and ASPs are applied individually to each subcategory to derive forecasts. These estimates are cross-checked by industry experts (marketing managers, product managers, CEOs, etc.) and further refined.

Overall findings are compared against market and procedure forecasts published by other sources to ensure reasonable estimates.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES AND TABLES

EXECUTIVE SUMMARY

METHODOLOGY

1.0 LATIN AMERICAN FACIAL INJECTABLE MARKET

• 1.1 Market Overview
• 1.2 Market Analysis
  • 1.2.1 Key Report Updates
  • 1.2.2 Product Overview
  • 1.2.3 Procedures
    • 1.2.3.1 Market Definition
  • 1.2.4 Market Forecast
    • 1.2.4.1 Brazilian Facial Injectable Market
    • 1.2.4.2 Mexican Facial Injectable Market
    • 1.2.4.3 Argentine Facial Injectable Market
  • 1.2.5 Market Drivers and Limiters
    • 1.2.5.1 Market Drivers
    • 1.2.5.2 Market Limiters
• 1.3 Competitive Analysis
  • 1.3.1 Competitive Landscape
  • 1.3.2 Market Shares
  • 1.3.3 Competitor Discussions (in Alphabetical Order)
    • Allergan
    • Ipsen
    • Lanzhou Institute of Biological Products
    • Metacrill
    • Q-Med
    • Other
  • 1.3.4 Emerging Competitors
    • Merz Pharmaceuticals

2.0 BOTULINUM TOXIN MARKET

• 2.1 Market Overview
• 2.2 Market Analysis
  • 2.2.1 Product Overview
  • 2.2.2 Market Forecast
  • 2.2.3 Market Drivers and Limiters
    • 2.2.3.1 Market Drivers
    • 2.2.3.2 Market Limiters
• 2.3 Competitive Analysis
  • 2.3.1 Competitive Landscape
  • 2.3.2 Market Shares

3.0 DERMAL FILLER MARKET

• 3.1 Market Overview
• 3.2 Market Analysis
  • 3.2.1 Product Overview
    • 3.2.1.1 Hyaluronic Acid Fillers
      • Standard HA
      • Rejuvenation HA
    • 3.2.1.2 Particle and Polymer Fillers
  • 3.2.2 Market Forecast
    • 3.2.2.1 Hyaluronic Acid Fillers
    • 3.2.2.2 Particle and Polymer Fillers
  • 3.2.3 Market Drivers and Limiters
    • 3.2.3.1 Market Drivers
    • 3.2.3.2 Market Limiters
• 3.3 Competitive Analysis
  • 3.3.1 Competitive Landscape
    • 3.3.1.1 Hyaluronic Acid Filler Segment
    • 3.3.1.2 Particle and Polymer Filler Segment
  • 3.3.2 Market Shares

APPENDIX A: MRG ACRONYMS AND INITIALISMS

APPENDIX B: SUPPLEMENTAL FIGURES

LIST OF FIGURES AND TABLES

TABLE OF CONTENTS

LIST OF FIGURES AND TABLES

EXECUTIVE SUMMARY

• Figure 1: Facial Injectable Market, by Segment, Latin America (US$), 2009 - 2015
• Figure 2: BTX Market, by Country, Latin America (US$), 2009 - 2015
• Figure 3: Dermal Filler Market, by Segment, Latin America (US$), 2009 - 2015
• Table 1: Companies Mentioned in This Report

METHODOLOGY

• Table 2: Average Currency Exchange Rates, 2010

1.0 LATIN AMERICAN FACIAL INJECTABLE MARKET

• Figure 4: Facial Injectable Market, by Segment, Latin America (US$), 2009 - 2015
• Table 3: Key Report Updates, 2011
• Table 4: Common Facial Injectable Products, Latin America, 2010
• Table 5: Common Facial Injectable Indications, by Type, Latin America, 2010
• Table 6: Facial Injectable Procedures, by Segment, Latin America, 2009 - 2015
• Table 7: Facial Injectable Procedures, by Country, Latin America, 2009 - 2015
• Table 8: BTX Procedures, by Country, Latin America, 2009 - 2015
• Table 9: Dermal Filler Procedures, by Country, Latin America, 2009 - 2015
• Table 10: HA Dermal Filler Procedures, by Country, Latin America, 2009 - 2015
• Table 11: PPF Procedures, by Country, Latin America, 2009 - 2015
• Table 12: Volume of Facial Injectable Product per Procedure, by Product
• Figure 5: Facial Injectable Market, by Country, Latin America (US$), 2009 - 2015
• Table 13: Facial Injectable Market, by Segment, Latin America (US$), 2009 - 2015
• Table 14: Facial Injectable Market Growth, by Segment, Latin America, 2010 - 2015
• Table 15: Facial Injectable Market, by Segment, as a % of Total, Latin America, 2009 - 2015
• Table 16: Facial Injectable Market, by Country, Latin America (US$), 2009 - 2015
• Table 17: Facial Injectable Market, by Country, Latin America (Local Currency), 2009 - 2015
• Table 18: Facial Injectable Market Growth, by Country, Latin America, 2009 - 2015
• Table 19: Facial Injectable Market, by Country, as a % of Total, Latin America 2009 - 2015
• Table 20: Drivers and Limiters of the Facial Injectable Market, Latin America
• Figure 6: Leading Competitors in the Facial Injectable Market, as a % of Total, Latin America, 2010
• Table 21: Leading Competitors in the Facial Injectable Market, by Segment, as a % of Total, Latin America, 2010

2.0 BOTULINUM TOXIN MARKET

• Figure 7: BTX Market, by Country, Latin America (US$), 2009 - 2015
• Table 22: Common Cosmetic BTX Products, Latin America, 2010
• Table 23: BTX Market, by Country, Latin America (US$), 2009 - 2015
• Table 24: BTX Market, by Country, Latin America (Local Currency), 2009 - 2015
• Table 25: BTX Market Growth, by Country, Latin America, 2009 - 2015
• Table 26: BTX Market, by Country, as a % of Total, Latin America, 2009 - 2015
• Table 27: Drivers and Limiters of the BTX Market, Latin America
• Table 28: Leading Competitors in the BTX Market, by Country, as a % of Total, Latin America, 2010

3.0 DERMAL FILLER MARKET

• Figure 8: Dermal Filler Market, by Segment, as a % of Total, Latin America, 2010 and 2015
• Table 29: Common HA Dermal Filler Products, Latin America, 2010
• Table 30: Common PPF Products, Latin America, 2010
• Table 31: Dermal Filler Market, by Segment, Latin America (US$), 2009 - 2015
• Table 32: Dermal Filler Market, by Country and Segment, Latin America (Local Currency), 2009 - 2015
• Table 33: Dermal Filler Market Growth, by Segment, Latin America, 2010 - 2015
• Table 34: Dermal Filler Market, by Segment, as a % of Total, Latin America, 2009 - 2015
• Table 35: HA Dermal Filler Market, by Country, Latin America (US$), 2009 - 2015
• Table 36: HA Dermal Filler Market, by Country, Latin America (Local Currency), 2009 - 2015
• Table 37: HA Dermal Filler Market Growth, by Country, Latin America, 2010 - 2015
• Table 38: HA Dermal Filler Market, by Country, as a % of Total, Latin America, 2009 - 2015
• Table 39: PPF Market, by Country, Latin America (US$), 2009 - 2015
• Table 40: PPF Market, by Country, Latin America (Local Currency), 2009 - 2015
• Table 41: PPF Market Growth, by Country, Latin America, 2010 - 2015
• Table 42: PPF Market, by Country, as a % of Total, Latin America, 2009 - 2015
• Table 43: Drivers and Limiters of the Dermal Filler Market, Latin America
• Table 44: Leading Competitors in the Dermal Filler Market, by Segment, as a % of Total, Latin America, 2010
• Table 45: Leading Competitors in the HA Dermal Filler Market, by Country, as a % of Total, Latin America, 2010
• Table 46: Leading Competitors in the PPF Market, by Country, as a % of Total, Latin America, 2010

APPENDIX A: MRG ACRONYMS AND INITIALISMS

MRG Acronyms and Initialisms

APPENDIX B: SUPPLEMENTAL FIGURES

• Figure 9: Facial Injectable Market, by Segment, Latin America (US$), 2009 - 2015 (Detailed Format)
• Figure 10: BTX Market, by Country, Latin America (US$), 2009 - 2015 (Detailed Format)
• Figure 11: Dermal Filler Market, by Segment, Latin America (US$), 2009 - 2015 (Detailed Format)

Press Release

顏面注射劑市場：拉丁美洲製造商與違法產品競爭

相關商品

矚目市場調查報告書

全球的美容外科手術資料庫

Global Aesthetics Procedure Volumes Database

價格 : US $ 20000

Millennium Research Group發行的醫療設備相關市場調查報告書

歐洲的重病患者管理用資訊系統市場:2012年

European Markets for High-Acuity Information Systems 2012

價格 : US $ 5995

出版日期 : 2012年04月

亞太地區的經導管栓塞·阻塞設備市場:2012年

Asia Pacific Markets for Transcatheter Embolization and Occlusion Devices 2012

價格 : US $ 6995

出版日期 : 2012年04月

歐洲的整形外科用軟組織解決方案市場:2012年

European Markets for Orthopedic Soft Tissue Solutions 2012

價格 : US $ 5995

出版日期 : 2012年03月

Email Alert(Email 通知) - 最新市場調查報告書

GII 將每天定期更新最新市場調查報書資訊，選擇您有興趣的市場分類，我們將用Email的方式讓您收到最新訊息!